Pennant Group earnings date
Pennant Group (1ZU) Q3 2026 Earnings Report
DE:1ZU Q3 2026 EPS Results
- Actual EPS
- EUR 0.32
- Consensus EPS
- EUR 0.32
- Beat/Miss
- Missed by -EUR 0.01
- One Year Ago EPS
- EUR 0.27
DE:1ZU Q3 2026 Revenue Results
- Actual Revenue
- EUR 274.91M
- Expected Revenue
- EUR 272.27M
- Beat/Miss
- Beat by +EUR 2.65M
- YoY Revenue Growth
- +31.96%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/04/2026
- Time
- After Close
- Conference Call
- Wednesday, November 4, 2026
Pennant Group's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
The call was positive overall, with strong revenue, EBITDA, EPS, admissions, census, clinical-quality, acquisition, and integration performance, along with reaffirmed full-year guidance. The main negatives were broad-based elevated benefits costs, short-term senior living occupancy and leadership-capacity challenges, lower Southeast home health revenue per episode, transition disruption, and management's concerns about insufficient reimbursement and regulatory burdens.
Management reaffirmed its full-year guidance and said it expects to hit its annual guidance, with the Amedisys and UnitedHealth integration expected to be completed in Q4 and disruption potentially modestly impacting results through the end of the year. Benefits expense was about 50 bps of revenue in Q3, and management anticipates similar in Q4. Senior living occupancy recovery is expected to make Q4 “a step in the right direction,” with a 9-quarter optimization period and 3 to 4 quarters as the expected timeline to get to accretive for communities that are significantly distressed; management also sees the opportunity to turn this into a real positive for 2027.
- Strong Third-Quarter Financial PerformanceQ3 revenue was $302.3 million, up 32% year over year. Adjusted EBITDA was $24.7 million, up 42.4%; adjusted EBITDA prior to NCI was $26.1 million, up 44%; and adjusted diluted EPS was $0.35, up 16.7%.
- Broad-Based Patient and Resident GrowthPennant was serving nearly 40% more home health patients, 35% more hospice patients, and 10% more senior living residents than one year earlier.
- Home Health and Hospice Segment GrowthHome health and hospice segment revenue was $239.8 million, up $66.2 million or 38.2%. Segment adjusted EBITDA was $38.1 million, up $11.3 million or 42%, while adjusted EBITDA prior to NCI was $39.5 million, up $11.9 million or 43%. Growth was driven by strong mature operations and the effective transition of newly acquired operations.
- Home Health Admissions and Same-Store PerformanceTotal home health admissions grew 39.4% and Medicare admissions grew 38%. Same-store total admissions increased 8%, Medicare admissions increased 12%, and revenue per episode increased 1.6% as operators offset the Medicare rate cut.
- Strong Hospice GrowthTotal hospice admissions increased 31.8%, total average daily census increased 34.6%, and revenue per day improved 2.1%. Same-store hospice admissions increased 3.1%, average daily census increased 13%, and revenue per day improved 3.5%.
- Improved Same-Store Margins and Clinical OutcomesDespite the increase in benefits costs, same-store margin increased 80 basis points year over year. The potentially preventable hospitalization rate improved 10 basis points to 9.9%, compared with an industry average of 10.8%, and the CMS-reported hospice quality composite score increased to 98.3%, compared with an industry average of 96.2%.
- Senior Living Revenue GrowthSenior living segment revenue was $62.4 million, up 12.6%, and adjusted EBITDA was $5.7 million, up 3%, compared with the prior-year quarter.
- Leadership Development PipelinePennant added more than 100 CEOs-in-training during the year, continued robust C-level training, and graduated more than 30 senior living CEOs-in-training. Management said it maintains a robust leadership pipeline.
- Continued Investment in Operating InfrastructurePennant has invested heavily in developing leaders, strengthening clusters, expanding its geographic footprint, and building infrastructure to support a larger organization. The company continues to focus on leadership development, clinical excellence, margin, growth, and employee experience.
- UnitedHealth and Amedisys Integration ProgressIntegration of the 54 locations acquired from UnitedHealth and Amedisys in the Southeast was nearly complete. Branding, leadership, and EMR transitions were completed, including the EMR transition on October 31. Management said the company remained ahead of its initial and updated guidance expectations and made no changes to its expectations.
- Acquisition and Real Estate ExpansionPennant acquired the real estate and operations of River Centre Assisted Living, a 63-unit community in Tucson, Arizona, on August 1, doubling the number of communities operated in Tucson during 2026. In September, it acquired the real estate associated with Mainplace Senior Living in Orange, California, after improving the operation under a triple-net lease since 2019.
- Opportunistic Senior Living Acquisition StrategyManagement said many newly added communities were acquired at low occupancy and at substantial discounts to market rates, creating opportunities for organic growth. The company continues to evaluate acquisition opportunities in both segments and expects to remain active in home health and hospice while selectively pursuing non-disruptive senior living acquisitions.
- Strong Financial Position and Cash GenerationAt quarter end, Pennant had $103 million outstanding on its line of credit, $18.4 million of cash, net debt to adjusted EBITDA of 1.95x, and $25.1 million of cash flow provided by operations in Q3.
- Successful Local Operating ExamplesSymbii Home Health and Hospice had a 5-star Home Health rating, a potentially preventable hospitalization rate of 6.9% versus a national average of 10.8%, 33% compound annual revenue growth, and 35% compound annual EBITDA growth over the last three years. Harvest Home increased occupancy to 91%, improved turnover by over 20%, and achieved almost 20% revenue growth and 276% EBITDA growth since joining Pennant in early 2025.
- Managed Care and Payer OpportunitiesManagement reported progress with its payer strategy and relations team and said payers are seeking high-quality partners that can deliver care efficiently. Pennant cited its hospitalization rates, star ratings, resource utilization, and clinical outcomes as data supporting its discussions with managed care providers.
- Full-Year Guidance ReaffirmedManagement stated that it continues to believe Pennant is positioned to achieve its full-year guidance and reaffirmed that it expects to hit its annual guidance.
DE:1ZU Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | 0.33- | 0.31 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 0.320.32 | 0.27 | 16.67% (+0.05) | |
| Aug 05, 2026 | 2026 (Q2) | 0.300.33 | 0.25 | 33.33% (+0.08) | |
| May 06, 2026 | 2026 (Q1) | 0.280.29 | 0.25 | 18.52% (+0.05) | |
| Feb 25, 2026 | 2025 (Q4) | 0.290.31 | 0.22 | 41.67% (+0.09) | |
| Nov 05, 2025 | 2025 (Q3) | 0.260.27 | 0.24 | 15.38% (+0.04) | |
| Aug 06, 2025 | 2025 (Q2) | 0.250.25 | 0.22 | 12.50% (+0.03) | |
| May 06, 2025 | 2025 (Q1) | 0.220.25 | 0.18 | 35.00% (+0.06) | |
| Feb 27, 2025 | 2024 (Q4) | 0.220.22 | 0.2 | 9.09% (+0.02) | |
| Nov 06, 2024 | 2024 (Q3) | 0.210.24 | 0.18 | 30.00% (+0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

